Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04942613
Other study ID # E3730-P
Secondary ID 21-2773
Status Completed
Phase N/A
First received
Last updated
Start date October 22, 2021
Est. completion date September 8, 2023

Study information

Verified date September 2023
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aims of this study are to determine the feasibility and acceptability of a multicomponent telerehabilitation program for medically complex older Veterans and to preliminarily assess participant outcomes (physical activity, physical function, quality of life, loneliness) to the program.


Description:

The aims of this study are to determine the feasibility and acceptability of the multicomponent telerehabilitation program and to preliminarily assess participant outcomes. The multicomponent program/intervention consists of 3 core components: 1) high-intensity rehabilitation interventions, 2) biobehavioral interventions, and 3) social support. The delivery of the program is supported by various technologies allowing for synchronous and asynchronous care and monitoring. Synchronous telerehabilitation will occur individually and in virtual groups. Feasibility and acceptability will be assessed by Veteran adherence to program components and validated surveys. Preliminary responsiveness will be assessed primarily by change in 7-day average step count and secondarily by other physical function tests and patient reported outcome measures. Study findings will have immediate clinical impact as they will guide implementation of safe and effective telerehabilitation strategies for medically complex older Veterans who lack access to standard in-person rehabilitation services.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date September 8, 2023
Est. primary completion date August 7, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - 60 years of age and older - Multiple chronic conditions (Charlson Comorbidity Index 3) - Impaired physical function (< or = 10 repetitions on 30 second sit to stand test) Exclusion Criteria: - Life expectancy < 12 months - Acute or progressive neurological disorder (e.g. Amyotrophic Lateral Sclerosis, recent stroke) - Moderate to severe dementia without caregiver assistance (< 18 on telephone Montreal Cognitive Assessment (MoCA Blind) - Unstable medical condition precluding safe participation in progressive rehabilitation (e.g. unstable angina)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Motivational Interviewing Techniques
Motivational Interviewing Techniques including but not limited to open-ended questions, reflection, affirmations, and summary will be used to build participant rapport, support behavior change (physical activity), and facilitate program engagement.
Other:
Physical Therapy Interventions
strengthening, balance, functional activities, stretching, breathing, aerobic endurance exercise
Education
Education on general health topics which may include the following: basic nutrition, stress reduction, sleep hygiene
Qualitative Interview
Qualitative interview to explore patient perspectives of the multicomponent telerehabilitation program (physical therapy, biobehavioral interventions, technology, and social support interventions) and how they contribute to program engagement and participation as well as changes in physical activity.

Locations

Country Name City State
United States Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora Colorado

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence Adherence will be measured as a proportion of the number of sessions attended out of the number prescribed per protocol Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)
Secondary Physical Activity Physical activity will be measured via accelerometry and will include average 7-day step count Change from Baseline to 12 weeks
Secondary Feasibility of the Program Feasibility will be measured through a validated survey: Feasibility of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. Higher scores indicate greater feasibility of the program Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)
Secondary Qualitative Interview #2 Individual key informant interview conducted through the same virtual platform participants will have used throughout program participation. Interviews will last approximately 30-45 minutes, and the investigators will attempt to interview all participants who completed Qualitative Interview #1. Questions will explore factors that participants associate with maintenance of physical activity up to 6 months after program completion, with an emphasis on social support, strategies learned from biobehavioral interventions, and technology. to occur within 3 to 6 months of Qualitative Interview #1
Secondary Acceptability of the Program Acceptability will be measured through a validated survey: Acceptability of Intervention Measure consists of 4 items rated on a 5-point Likert scale (1) completely disagree to (5) completely agree. Higher scores indicated greater acceptability of the program. Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)
Secondary Participant Recruitment Recruitment will be tracked as part of feasibility and to inform a future trial. Recruitment will be reported as a proportion of those enrolled out of the total number screened via phone screen. through study completion, an average of 1.5 years
Secondary Satisfaction of the Program Participation satisfaction with care provided via telerehabilitation will be assess via the VA's approved survey: V-signals. It consists of 11 items rated on a 5-point Likert scale (strongly disagree to strongly agree), and higher scores indicated better satisfaction Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)
Secondary Safety Event Count The Safety Event Count is the cumulative number of adverse events and severe adverse events counted from baseline to program end. Events will be categorized by type Program end- 12 weeks in Intervention group (Group1); 24 weeks in Waitlist control (Group2)
Secondary Exercise readiness to change Four-item questionnaire used to determine an individual's stage of change (pre-contemplation, contemplation, preparation, action, or maintenance) Change from Baseline to 12 weeks
Secondary Self-efficacy for Exercise Nine item questionnaire used to measure an individual's self-efficacy for exercising under different conditions. Each item is rated on a scale of 0 (not confident) to 10 (confident), and higher scores indicated better self-efficacy. Change from Baseline to 12 weeks
Secondary 30 second sit to stand The test uses a standard height chair and requires the participant to stand up and sit down as many times as possible in 30 seconds. More completions indicate better physical function. Change from Baseline to 12 weeks
Secondary Arm curl test This is a functional performance test for upper body strength and is performed on each arm (one arm at a time). It requires the participant to perform as many arm curls (biceps curls) as possible in 30 seconds. Males use an 8lb weight and females use a 5lb weight. Scores are continuous, and higher scores indicate greater arm strength (better outcome) Change from Baseline to 12 weeks
Secondary 2-minute step test This is a functional performance test for aerobic endurance. It requires participants to march in place for 2 minutes (alternating legs), and the score is the number of repetitions completed on the right leg. Scores are continuous, and higher scores indicate better aerobic endurance. Change from Baseline to 12 weeks
Secondary Activity Measure for Post-Acute Care (AM-PAC) basic mobility outpatient routine short form This questionnaire consists of 18 items rated on a 4-point Likert scale from 1 (unable) to 4 (none) to address the prompt: How much difficulty do you currently have. Higher scores indicated better mobility and less impairment/disability Change from Baseline to 12 weeks
Secondary 3-Item Loneliness Scale This scale has three items and a simplified set of response categories that is designed to measure overall loneliness. Score range: 3-9. Higher scores indicate higher loneliness. Change from Baseline to 12 weeks
Secondary PROMIS-29+2 Profile v2.1 This is a patient reported outcome measure to assess quality of life (summative score), social support (subscale), and mental health (subscale). It is a 29-item questionnaire and most items are rated on a 5-point Likert scale. There is 1 pain intensity item rated on a 0 (no pain) to 10 (worst pain imaginable) scale. Higher scores for subscales listed indicate better quality of life, social support, and mental health. Change from Baseline to 12 weeks
Secondary Participant Retention Participant retention will be tracked as part of feasibility and to inform a future trial. Retention will be reported as a proportion of the total number of participants who complete all outcome measure timepoints out of the total who complete baseline measures. through study completion, an average of 1.5 years
Secondary Qualitative Interview #1 Individual key informant interview conducted through the same virtual platform participants will have used throughout program participation. Interviews will last approximately 45-60 minutes, and participants will be purposively sampled according to group randomization. Questions will explore factors that participants associate with program engagement and participation as well as short-term changes in physical activity. to occur within 3 weeks of program completion
See also
  Status Clinical Trial Phase
Recruiting NCT05421143 - Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
Completed NCT02928939 - Therapeutic Conflicts and Multimorbidity
Recruiting NCT05560451 - Telehealth-delivered Peer Support to Improve Quality of Life Among Veterans With Multimorbidity N/A
Completed NCT03697772 - Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
Recruiting NCT03439410 - Clinical Complexity in Internal Medicine Wards. San MAtteo Complexity Study
Active, not recruiting NCT05985044 - Living With Multimorbidity: CO-ORDINATE Program N/A
Completed NCT02866799 - Multi-PAP: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy N/A
Recruiting NCT05406193 - A New Care Model for Patients With Complicated Multimorbidity N/A
Completed NCT02962687 - Video-Enhanced Care Management for Medically Complex Veterans N/A
Completed NCT02664454 - Compared Efficacy of Nurse-led and GP-led Geriatric Assessment in PrImary Care N/A
Not yet recruiting NCT04391218 - A Multidisciplinary Intervention Including a Clinical Decision Support System and an App for Drug Therapy Management in Older Patients N/A
Completed NCT03126565 - Evaluation of the Philips Lifeline CareSage Risk Assessment System N/A
Recruiting NCT04856202 - ACP in Older Patients With Multimorbidity: a Randomized Pilot N/A
Completed NCT03912103 - Interdisciplinary Medication Review Interventions in an Integrated Outpatient Department. N/A
Completed NCT04955600 - Digital Technology in the Home of Elderly Patients With Multimorbidity
Completed NCT05893212 - Nature Walks or Exercise as a Group Activity, the Effect Well-being, Sleep and Activity. N/A
Completed NCT03528005 - Effectiveness of Integrated Care Network N/A
Completed NCT03088982 - Preventing Decompensation Among Multimorbid Outpatients in Residential Care. A Cohort Study With a Six-month Follow-up. N/A
Completed NCT04326062 - Supporting Prescribing in Irish Primary Care: General Practice Pharmacist Study N/A
Not yet recruiting NCT06431932 - Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity Phase 1/Phase 2